Andriawan, N. (2023). Pembrolizumab as A Therapy for Triple-Negative Breast Cancer : Systematic Review. Journal Of Herbal, Clinical And Pharmaceutical Science (HERCLIPS), 5(01), 58-67. doi:10.30587/herclips.v5i01.6285